Posted by Michael Wonder on 13 Nov 2020
Public Summary Documents - PBAC July 2020 meeting
13 November 2020 - The Public Summary Documents (first time rejections and deferrals) from the July 2020 PBAC meeting are now available.
The MAESTrO PBAC version has been updated with respect to:
- Comparators (primary, secondary)
- Clinical trials
- Primary outcomes
- Patient reported outcomes
- Economic model type
- Economic model time horizon
Links to the PSDs have also been added.
The publication of the second round of Public Summary Documents from the July 2020 PBAC meeting has also revealed additional outcomes for ribociclib succinate (Kisqali).
